# Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC)

> **NCT06499896** · PHASE2 · RECRUITING · sponsor: **Diwakar Davar** · enrollment: 30 (estimated)

## Conditions studied

- Immune-mediated Colitis (IMC)
- Immune-related Dermatitis

## Interventions

- **BIOLOGICAL:** MTP-101-C

## Key facts

- **NCT ID:** NCT06499896
- **Lead sponsor:** Diwakar Davar
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-01-23
- **Primary completion:** 2027-09-30
- **Final completion:** 2031-09-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-02-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06499896

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06499896, "Healthy-donor Microbiome MTP-101-C in Steroid Relapse/Refractory Immune-related Cutaneous Adverse Events (irCAEs) and Immune-mediated Colitis (IMC)". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06499896. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*